Cancer firm Diakonos raises $11.4 million

The Houston biotechnology firm Diakonos Oncology will begin a midstage clinical trial of its dendritic cell vaccine for cancer with the help of $11.4 million in seed financing. The drug candidate is designed to boost a patient’s immune cells—specifically, Th1 cells—to fight glioblastomas, pancreatic cancer, and angiosarcoma. Diakonos is developing other compounds for head and neck cancers and HER2-positive breast cancer. The investment firm Restem led the seed funding round.

Authors

Publication Details

Journal
C&EN Global Enterprise
Published
2024-09-02
DOI
https://doi.org/10.1021/cen-10227-buscon17
Primary Topic
Science, Research, and Medicine
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cancer firm Diakonos raises $11.4 million

Rowan Walrath
C&EN Global Enterprise
Science, Research, and Medicine
article

Cancer firm Diakonos raises $11.4 million

Rowan Walrath
article en

Abstract

The Houston biotechnology firm Diakonos Oncology will begin a midstage clinical trial of its dendritic cell vaccine for cancer with the help of $11.4 million in seed financing. The drug candidate is designed to boost a patient’s immune cells—specifically, Th1 cells—to fight glioblastomas, pancreatic cancer, and angiosarcoma. Diakonos is developing other compounds for head and neck cancers and HER2-positive breast cancer. The investment firm Restem led the seed funding round.

C&EN Global EnterpriseVol. 102(27)
Openalex Percentile: Top 79%
Science, Research, and Medicine
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Cancer firm Diakonos raises $11.4 million — Rowan Walrath · C&EN Global Enterprise (2024) | TGRS Research Map | TGRS